Zeb1-induced Metabolic Reprogramming of Glycolysis is Essential for Macrophage Polarization in Breast Cancer

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2022 Mar 5

PMID 35246504

Authors

Huimin Jiang

Huimin Wei

Hang Wang

Zhaoyang Wang

Jianjun Li

Yang Ou

Xuechun Xiao

Wenhao Wang

Antao Chang

Wei Sun

Li Zhao

Shuang Yang

Affiliations

Soon will be listed here.

Abstract

Aerobic glycolysis (the Warburg effect) has been demonstrated to facilitate tumor progression by producing lactate, which has important roles as a proinflammatory and immunosuppressive mediator. However, how aerobic glycolysis is directly regulated is largely unknown. Here, we show that ectopic Zeb1 directly increases the transcriptional expression of HK2, PFKP, and PKM2, which are glycolytic rate-determining enzymes, thus promoting the Warburg effect and breast cancer proliferation, migration, and chemoresistance in vitro and in vivo. In addition, Zeb1 exerts its biological effects to induce glycolytic activity in response to hypoxia via the PI3K/Akt/HIF-1α signaling axis, which contributes to fostering an immunosuppressive tumor microenvironment (TME). Mechanistically, breast cancer cells with ectopic Zeb1 expression produce lactate in the acidic tumor milieu to induce the alternatively activated (M2) macrophage phenotype through stimulation of the PKA/CREB signaling pathway. Clinically, the expression of Zeb1 is positively correlated with dysregulation of aerobic glycolysis, accumulation of M2-like tumor-associated macrophages (TAMs) and a poor prognosis in breast cancer patients. In conclusion, these findings identify a Zeb1-dependent mechanism as a driver of breast cancer progression that acts by stimulating tumor-macrophage interplay, which could be a viable therapeutic target for the treatment of advanced human cancers.

Citing Articles

SEC61G Facilitates Brain Metastases via Antagonizing PGAM1 Ubiquitination and Immune Microenvironment Remodeling in Non-Small Cell Lung Cancer.

Zhou C, Yang Y, Cui H, Li S, Wang Z, Chen L Int J Biol Sci. 2025; 21(4):1436-1458.

PMID: 39990664 PMC: 11844280. DOI: 10.7150/ijbs.109187.

"Friends or foes": a new perspective of tumour metabolic transcriptional modification.

Shi T, Geng Q, Wang Z, Wen C, Xu J, Jiao Y Cell Death Dis. 2025; 16(1):106.

PMID: 39962057 PMC: 11833121. DOI: 10.1038/s41419-025-07429-y.

VSIG4 tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1.

Pan Z, Chen J, Xu T, Cai A, Han B, Li Y J Exp Clin Cancer Res. 2025; 44(1):45.

PMID: 39920772 PMC: 11803937. DOI: 10.1186/s13046-025-03303-z.

Research progresses and hotspots on glucose metabolic reprogramming in breast cancer: a bibliometric analysis over the past two decades.

Huang L, Zhao W, Sun L, Niu D, Zhu X, Jin C Front Oncol. 2025; 14:1493996.

PMID: 39876898 PMC: 11772165. DOI: 10.3389/fonc.2024.1493996.

EIF4A3-induced circ_0022382 promotes breast cancer cell progression through the let-7a-5p/PI3K/AKT/mTOR signaling pathway and SLC7A11 axis.

Liu W, Zhang J, Zhang J, Ye Y, Zhu J, Yu Q Front Oncol. 2025; 14:1476731.

PMID: 39868374 PMC: 11758171. DOI: 10.3389/fonc.2024.1476731.

References

Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y . Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019; 21(4):498-510. DOI: 10.1038/s41556-019-0299-0. View

Hermans D, Gautam S, Garcia-Canaveras J, Gromer D, Mitra S, Spolski R . Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8 T cell stemness and antitumor immunity. Proc Natl Acad Sci U S A. 2020; 117(11):6047-6055. PMC: 7084161. DOI: 10.1073/pnas.1920413117. View

Cascone T, McKenzie J, Mbofung R, Punt S, Wang Z, Xu C . Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy. Cell Metab. 2018; 27(5):977-987.e4. PMC: 5932208. DOI: 10.1016/j.cmet.2018.02.024. View

Morel A, Ginestier C, Pommier R, Cabaud O, Ruiz E, Wicinski J . A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability. Nat Med. 2017; 23(5):568-578. DOI: 10.1038/nm.4323. View

Chao C, Chang C, Wu M, Ko H, Wang D, Hung M . MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis. J Clin Invest. 2014; 124(7):3093-106. PMC: 4071406. DOI: 10.1172/JCI73351. View

Fu R, Han C, Ni T, Di L, Liu L, Lv W . A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours. Nat Commun. 2019; 10(1):3210. PMC: 6642263. DOI: 10.1038/s41467-019-11278-7. View

Koppenol W, Bounds P, Dang C . Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011; 11(5):325-37. DOI: 10.1038/nrc3038. View

Viswanathan V, Ryan M, Dhruv H, Gill S, Eichhoff O, Seashore-Ludlow B . Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017; 547(7664):453-457. PMC: 5667900. DOI: 10.1038/nature23007. View

Elia I, Doglioni G, Fendt S . Metabolic Hallmarks of Metastasis Formation. Trends Cell Biol. 2018; 28(8):673-684. DOI: 10.1016/j.tcb.2018.04.002. View

10.

Dehne N, Mora J, Namgaladze D, Weigert A, Brune B . Cancer cell and macrophage cross-talk in the tumor microenvironment. Curr Opin Pharmacol. 2017; 35:12-19. DOI: 10.1016/j.coph.2017.04.007. View

11.

Franklin R, Liao W, Sarkar A, Kim M, Bivona M, Liu K . The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344(6186):921-5. PMC: 4204732. DOI: 10.1126/science.1252510. View

12.

Castano Z, San Juan B, Spiegel A, Pant A, DeCristo M, Laszewski T . IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nat Cell Biol. 2018; 20(9):1084-1097. PMC: 6511979. DOI: 10.1038/s41556-018-0173-5. View

13.

Higashi Y, Moribe H, Takagi T, Sekido R, Kawakami K, Kikutani H . Impairment of T cell development in deltaEF1 mutant mice. J Exp Med. 1997; 185(8):1467-79. PMC: 2196278. DOI: 10.1084/jem.185.8.1467. View

14.

Chen X, Deng Y, Wang Z, Wei W, Zhou C, Zhang Y . Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death Dis. 2019; 10(7):508. PMC: 6602971. DOI: 10.1038/s41419-019-1748-1. View

15.

Li L, Liang Y, Kang L, Liu Y, Gao S, Chen S . Transcriptional Regulation of the Warburg Effect in Cancer by SIX1. Cancer Cell. 2018; 33(3):368-385.e7. DOI: 10.1016/j.ccell.2018.01.010. View

16.

Chen C, Bai L, Cao F, Wang S, He H, Song M . Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis. Oncogene. 2019; 38(23):4527-4539. DOI: 10.1038/s41388-019-0735-4. View

17.

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

18.

Zhang J, Zhou C, Jiang H, Liang L, Shi W, Zhang Q . ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer. Cell Death Dis. 2017; 8(4):e2732. PMC: 5477580. DOI: 10.1038/cddis.2017.154. View

19.

Qian B, Pollard J . Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141(1):39-51. PMC: 4994190. DOI: 10.1016/j.cell.2010.03.014. View

20.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View